#TMS #BrainHealth #Neuroplasticity #MentalHealthTreatment #PrecisionPsychiatry #BrainWellProgram #DrMizylDamayo #ParadiseBehavioralHealth To view or add a comment, sign in
Plasma micronutrient profile of prostate cancer cases is altered relative to healthy controls-results of a pilot study in south Australia
Debeer S, Le Luduec JB, Kaiserlian D, Laurent P, Nicolas JF, Dubois B, et al
Danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist, will undergo dose optimization studies in the second half of 2024 as Pfizer seeks to evaluate multiple doses of the formulation which they hope will inform the registration-enabling studies
Two of these, CJC-1295 and ipamorelin*, are peptides that can be administered to help support the production of growth hormone and alleviate various endocrine challenges